The Comparison of Wet Suction and Dry Suction Technique in EUS-FNA for the Outcomes in Pancreatic Solid Lesions

Not Applicable

Completed

• Conditions: Pancreatic Solid Lesions
• Interventions: Procedure: wet suction technique; Procedure: dry suction technique

• Registration Number: NCT03821974
• Lead Sponsor: The Third Xiangya Hospital of Central South University

Brief Summary

The objective of this randomized controlled trial is to evaluate whether wet suction technique (WST), compared with dry suction technique (DST), shall present a better outcome with regard to the diagnostic yield and specimen quality of patients with solid lesions in the pancreatics.

Detailed Description

Endoscopic ultrasound guided fine-needle aspiration (EUS-FNA) has become an inevitable indispensable method for acquiring a pathological diagnosis in a variety of clinical conditions. It has been widely used due to the high sensitivity, specificity and safety. In order to improve the puncture efficiency of FNA, many domestic and oversea scholars have conducted several clinical trials. Among them, there are many studies on the type of needle, needle pattern, slow pull or vacuum suction, and there are only two related reports on wet suction (saline) and dry suction technique. There still have many controversies in the researchers about which technique is more dominant in the wet or dry suction. The wet suction technique is relying on pre-flushing the needle with saline to replace the column of air with fluid followed by aspiration at the proximal end, using a prefilled suction syringe with saline. It has been suggested that the presence of a saline-solution column might keep the needle from getting clogged while avoiding the inherent inconvenience of a metal stylet, so that it can improve the quality of specimens, diminish the contamination of blood, and increase the diagnostic yield and accuracy. Wet suction may become the development trend of EUS-FNA in the future because the application of wet suction is expected to improve the diagnostic efficiency and the quality of samples in FNA.

Study Timeline

• Study Start: 2019-01-03
• Study First Submitted: 2019-01-15
• Study First Submitted QC: 2019-01-25
• Study First Posted: 2019-01-30
• Primary Completion: 2019-09-30
• Study Completion: 2020-03-31
• Status Verified: 2021-06
• Last Update Submitted: 2021-06-14
• Last Update Posted: 2021-06-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Age > 18 years, < 80 years
2. female or male
3. Patients are required to undergo EUS-FNA after undergoing imaging examination (MRI, CT, or ultrasonography) which identify that the pancreatic lesions are existing and solid.
4. Agree to attend this study and signed informed consent letter

Exclusion Criteria

1. bad physical condition, including hemoglobin ≤ 8.0 g/dl, severe cardiorespiratory dysfunction, and so on
2. Coagulopathy (platelet count < 50,000/mm3, international normalized ratio > 1.5) or having taken oral anticoagulation agents such as aspirin or warfarin in the previous week
3. Be rejected by anesthesia
4. Acute pancreatitis in the previous 2 weeks
5. Pregnant or lactation period
6. Psychiatric disease, drug addiction, or other reason for unreliable follow-up or questionnaires
7. Don't agree to attend this study and absence of informed consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
wet group	dry suction technique	The sequence of the technique of the puncture is wet-dry-wet-dry.
wet group	wet suction technique	The sequence of the technique of the puncture is wet-dry-wet-dry.
dry group	wet suction technique	The sequence of the technique of the puncture is dry-wet-dry-wet.
dry group	dry suction technique	The sequence of the technique of the puncture is dry-wet-dry-wet.

Primary Outcome Measures

Name	Time	Method
The primary outcome is defined as the overall diagnosis yield of solid lesions by EUS-FNA with each aspiration technique.	20 weeks	The primary outcome is defined as the overall diagnosis yield of solid lesions by EUS-FNA with each aspiration technique.

Secondary Outcome Measures

Name	Time	Method
The forth outcome is the diagnose yield in malignant solid lesions by EUS-FNA with each aspiration technique.	20 weeks	The forth outcome is the diagnose yield in malignant solid lesions by EUS-FNA with each aspiration technique.
The third outcome is the diagnose yield in benign solid lesions by EUS-FNA with each aspiration technique.	20 weeks	The third outcome is the diagnose yield in benign solid lesions by EUS-FNA with each aspiration technique.
The second outcome is defined as the diagnose yield of first pass of solid lesions by EUS-FNA with each aspiration technique.	20 weeks	The second outcome is defined as the diagnose yield of first pass of solid lesions by EUS-FNA with each aspiration technique.
The fifth outcome is the diagnose yield in solid lesions in different parts of the pancreas by EUS-FNA with each aspiration technique.	20 weeks	The fifth outcome is the diagnose yield in solid lesions in different parts of the pancreas by EUS-FNA with each aspiration technique.

Trial Locations

Locations (1)

The third Xiangya Hospital of central south University; 🇨🇳 Changsha, Hunan, China